Pipeline

iVeena has nine products in late pre-clinical and research phase. Targeted indications include Post Surgery Cataract Inflammation, Macular Degeneration (Wet AMD), Diabetic Retinopathy, Glaucoma, and three orphan drug candidates.

iVeena Pipeline 0612172x  BDI-1 BDI-2 IVMed Wet and Gene IVMED Diabetic IVMED Glaucoma